UCB S.A.: all 580 studies

Page 1 of 6. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic BronchitisRecruitingNCT07725939Phase 2
• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis BronchiectasisRecruitingNCT07720375Phase 2
• A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic DiseasesRecruitingNCT07712939Phase 1
• A Clinical Study of Cizutamig in Thyroid Eye DiseaseRecruitingNCT07597200Phase 1
• SLC6A1-NDD Prospective Longitudinal Natural History StudyRecruitingNCT07531511
• A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeRecruitingNCT07503444Phase 3
• A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisRecruitingNCT07465289Phase 3
• A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisRecruitingNCT07463521Phase 3
• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruitingNCT07290036Phase 1
• Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia GravisRecruitingNCT07246564Phase 4
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisRecruitingNCT07219420Phase 3
• Clinical Study of Cizutamig in Systemic Lupus ErythematosusRecruitingNCT07215663Phase 1
• Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)RecruitingNCT07215650Phase 1
• A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating WomenRecruitingNCT06961747Phase 1
• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)RecruitingNCT06888193Phase 1
• An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisRecruitingNCT06668181Phase 3
• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusRecruitingNCT06617325Phase 3
• Doxecitine and Doxribtimine-Expanded AccessAvailableNCT06590493
• An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia GravisEnrolling by invitationNCT06435312Phase 3
• A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)RecruitingNCT06422923Phase 1/2
• A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia GravisRecruitingNCT06055959Phase 2/3
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))RecruitingNCT05135091Phase 3
• A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresRecruitingNCT05077904Phase 3
• A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresEnrolling by invitationNCT05076617Phase 3
• A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus ErythematosusEnrolling by invitationNCT04976322Phase 3
• A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresRecruitingNCT04715646Phase 3
• A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating WomenCompletedNCT06720714Phase 1Results posted
• A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study ParticipantsCompletedNCT06679413Phase 1Results posted
• A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy ParticipantsCompletedNCT06533475Phase 1Results posted
• A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult ParticipantsCompletedNCT06511076Phase 1Results posted
• A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia GravisCompletedNCT06471361Phase 3Results posted
• A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study ParticipantsCompletedNCT06312566Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque PsoriasisCompletedNCT06011733Phase 3Results posted
• A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part BCompletedNCT05845645Phase 1Results posted
• A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)CompletedNCT05681715Phase 3Results posted
• A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia SyndromeCompletedNCT05643794Phase 2Results posted
• An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's DiseaseTerminatedNCT05543252Phase 2Results posted
• An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 InhibitorsCompletedNCT05514873Phase 3Results posted
• A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study ParticipantsCompletedNCT05315947Phase 1Results posted
• A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study ParticipantsCompletedNCT05292131Phase 1Results posted
• A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyCompletedNCT05109234Phase 3Results posted
• A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With OsteoporosisCompletedNCT05067335Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque PsoriasisCompletedNCT05020249Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese SubjectsCompletedNCT04882540Phase 1Results posted
• A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune EncephalitisTerminatedNCT04875975Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Rozanolixizumab Administered Subcutaneously Via Manual Push Versus Syringe Driver to Healthy ParticipantsCompletedNCT04828343Phase 1Results posted
• A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid ArthritisCompletedNCT04740814Phase 1Results posted
• A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04718896Phase 2Results posted
• A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's DiseaseCompletedNCT04658186Phase 2Results posted
• A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia GravisCompletedNCT04650854Phase 3Results posted
• A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide TreatmentCompletedNCT04627285Phase 3Results posted
• A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04596995Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal SeizuresTerminatedNCT04519645Phase 2Results posted
• A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid TumorsCompletedNCT04393298Phase 1/2Results posted
• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusCompletedNCT04294667Phase 3Results posted
• A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study ParticipantsTerminatedNCT04255862Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT04242498Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT04242446Phase 3Results posted
• A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04224688Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04200456Phase 3Results posted
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)CompletedNCT04163016Phase 1Results posted
• A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic FunctionTerminatedNCT04136444Phase 1Results posted
• A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female ParticipantsTerminatedNCT04131517Phase 1Results posted
• A Study to Test the Cardiac Effects of Padsevonil in Healthy Study ParticipantsTerminatedNCT04126343Phase 1Results posted
• A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia GravisCompletedNCT04124965Phase 3Results posted
• Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia GravisCompletedNCT04115293Phase 3Results posted
• A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic ArthritisCompletedNCT04109976Phase 3Results posted
• A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study ParticipantsCompletedNCT04075409Phase 1Results posted
• A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT04051944Phase 2Results posted
• A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or CannabidiolTerminatedNCT04039919Phase 1Results posted
• Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing MyopathyTerminatedNCT04025632Phase 2Results posted
• A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study ParticipantsCompletedNCT04013191Phase 1Results posted
• A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs SyndromeTerminatedNCT03992196Phase 3Results posted
• A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia GravisCompletedNCT03971422Phase 3Results posted
• A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut SyndromeCompletedNCT03936777Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing SpondylitisCompletedNCT03928743Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial SpondyloarthritisCompletedNCT03928704Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompletedNCT03896581Phase 3Results posted
• A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompletedNCT03895203Phase 3Results posted
• A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT03861481Phase 2Results posted
• A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)CompletedNCT03766685Phase 3Results posted
• A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant EpilepsyTerminatedNCT03739840Phase 3Results posted
• A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown CauseTerminatedNCT03728933Phase 3Results posted
• A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilCompletedNCT03695094Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03598790Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03536884Phase 3Results posted
• Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of PadsevonilCompletedNCT03480243Phase 1Results posted
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure PatternCompletedNCT03478982Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03412747Phase 3Results posted
• A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03410992Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With EpilepsyCompletedNCT03405714Phase 2Results posted
• Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant EpilepsyCompletedNCT03373383Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03370133Phase 3Results posted
• Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant EpilepsyTerminatedNCT03370120Phase 2Results posted
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3Results posted
• A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing SpondylitisCompletedNCT03355573Phase 2Results posted
• A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromeCompletedNCT03355209Phase 3Results posted
• A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic ArthritisCompletedNCT03347110Phase 2Results posted
• A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of AgeCompletedNCT03340064Phase 3Results posted
• A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic SeizuresTerminatedNCT03325439Phase 3Results posted

← UCB S.A. overview and focus areas